Indication

Treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who are anaemic after treatment with a C5 inhibitor for at least 3 months.

Medicine details

Medicine name:
pegcetacoplan (Aspaveli)
SMC ID:
SMC2451
Pharmaceutical company
Swedish Orphan Biovitrum
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
02 May 2022